Add to ORKG© 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effects of gabapentin monotherapy for people with epileptic partial seizures with and without secondary generalisation
Contains fulltext : 18916.pdf (publisher's version ) (Open Access)Antiepiletic dru...
Editor's note: This is a summary of a nursing care-related systematic review from the Cochrane Libra...
Purpose: Observational studies may provide important information on the long-term effects of treatme...
© 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. This is a protocol for a C...
A randomized double-blind trial of gabapentin monotherapy in patients with newly diagnosed partial e...
BACKGROUND: The majority of people with epilepsy have a good prognosis and their seizures are well c...
This protocol for a Cochrane Review is out of date and has been withdrawn in order to adhere to Coch...
The results of three large, placebo-controlled, multicenter clinical trials of gabapentin as add-on ...
US Food and Drug Administration (USFDA) approved gabapentin as an adjuvant treatment for refractory ...
Gabapentin (GBP) possesses a well documented clinical efficacy in those types of focal epilepsy othe...
efficacy, and safety of gabapentin, a new antiepileptic drug (AED). Gabapentin's potential role...
Gabapentin is an antiepileptic drug (AED) by design expected to mimic the action of the neurotransmi...
BackgroundEpilepsy is a common neurological condition with a worldwide prevalence of around 1%. Appr...
To review the information available regarding the safety and tolerability of gabapentin (GBP)...
ObjectivesTo describe the process and results of the updated Swedish practice guidelines for monothe...
Contains fulltext : 18916.pdf (publisher's version ) (Open Access)Antiepiletic dru...
Editor's note: This is a summary of a nursing care-related systematic review from the Cochrane Libra...
Purpose: Observational studies may provide important information on the long-term effects of treatme...
© 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. This is a protocol for a C...
A randomized double-blind trial of gabapentin monotherapy in patients with newly diagnosed partial e...
BACKGROUND: The majority of people with epilepsy have a good prognosis and their seizures are well c...
This protocol for a Cochrane Review is out of date and has been withdrawn in order to adhere to Coch...
The results of three large, placebo-controlled, multicenter clinical trials of gabapentin as add-on ...
US Food and Drug Administration (USFDA) approved gabapentin as an adjuvant treatment for refractory ...
Gabapentin (GBP) possesses a well documented clinical efficacy in those types of focal epilepsy othe...
efficacy, and safety of gabapentin, a new antiepileptic drug (AED). Gabapentin's potential role...
Gabapentin is an antiepileptic drug (AED) by design expected to mimic the action of the neurotransmi...
BackgroundEpilepsy is a common neurological condition with a worldwide prevalence of around 1%. Appr...
To review the information available regarding the safety and tolerability of gabapentin (GBP)...
ObjectivesTo describe the process and results of the updated Swedish practice guidelines for monothe...
Contains fulltext : 18916.pdf (publisher's version ) (Open Access)Antiepiletic dru...
Editor's note: This is a summary of a nursing care-related systematic review from the Cochrane Libra...
Purpose: Observational studies may provide important information on the long-term effects of treatme...